Octa-Arginine-Modified Pegylated Liposomal Doxorubicin: An Effective Treatment Strategy for Non-Small Cell Lung Cancer

The present study aims to evaluate the efficacy of octa-arginine (R8)-modified PEGylated liposomal doxorubicin (R8-PLD) for the treatment of non-small cell lung cancer, for which the primary treatment modality currently consists of surgery and radiotherapy. Cell-penetrating peptide R8 modification o...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Biswas, Swati, Deshpande, Pranali P., Perche, Federico, Dodwadkar, Namita S., Sane, Shailendra D., Torchilin, Vladimir P.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2013
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3665647/
https://ncbi.nlm.nih.gov/pubmed/23419527
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.canlet.2013.02.020
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller